{"text": "AbbVie Option Alert: Jan 21 $125 Calls at the Ask: 8050 @ $0.76 vs 12202 OI; Earnings 10/29 Before Open [est] Ref=$108.205\n\nRelated Tickers: $ABBV\nRead more at: https://t.co/osStOClQbf", "id": "1441103508736909315", "author_id": "1254906887490936845", "created_at": "2021-09-23T18:13:45.000Z"}
{"text": "$BIIB A BUY! https://t.co/hkCDzyauhN\n\n$MSFT $AAPL $GOOG $FB $AMZN $DIS $V $TSLA $HD $MA $NFLX $WMT $JNJ $PFE $ABT $PYPL $BAC $JPM $KO $T $ORCL $VZ $MMM $SPY $UNH $DHR $TMO $MU $CAT $PG $TMO $CVX $NKE $D $CRM $MRK $ABBV $SBUX $XOM $COST $DG $LOW $CSCO $BA $DUK #SP500 #SPX500 #SPX", "id": "1441101357008576513", "author_id": "25762392", "created_at": "2021-09-23T18:05:12.000Z"}
{"created_at": "2021-09-23T17:03:49.000Z", "text": "The majority of their revenue has come from Vergenix FG and Vergenix STR (advanced wound care and soft tissue repair). This should change with the launch of dermal fillers with $ABBV as well as bioinks expected to launch in Q4. They also have a colab with $DDD in preclinical.", "author_id": "1357151404360613888", "id": "1441085907734466565"}
